Morbidity and Mortality of Total Pelvic Exenteration for Malignancy in the US.
Vigneswaran HT, Schwarzman LS, Madueke IC, David SM, Nordenstam J, Moreira D, Abern MR.
Ann Surg Oncol. 2021 May;28(5):2790-2800. doi: 10.1245/s10434-020-09247-2. Epub 2020 Oct 26.
PMID:33105501
Total Pelvic Exenteration, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Rectal Cancer with Associate Peritoneal Metastases: Surgical Strategies to Optimize Safety.
Tuech JJ, Pinson J, Nouhaud FX, Wood G, Clavier T, Sabourin JC, Di Fiore F, Monge M, Papet E, Coget J.
Cancers (Basel). 2020 Nov 23;12(11):3478. doi: 10.3390/cancers12113478.
PMID:33238384
Retrospective review of pelvic malignancies undergoing total pelvic exenteration.
Kuhrt MP, Chokshi RJ, Arrese D, Martin EW Jr.
World J Surg Oncol. 2012 Jun 15;10:110. doi: 10.1186/1477-7819-10-110.
PMID:22703863
[Laparoscopic Total Pelvic Exenteration of Locally Advanced Rectal Cancer Invading Urogenital Organs].
Matsui Y, Tokuhara K, Ueyama Y, Yoshioka K, Sekimoto M.
Gan To Kagaku Ryoho. 2021 Aug;48(8):1073-1076.
PMID:34404080
Total pelvic exenteration for locally advanced and locally recurrent rectal cancer in the elderly.
Hagemans JAW, Rothbarth J, Kirkels WJ, Boormans JL, van Meerten E, Nuyttens JJME, Madsen EVE, Verhoef C, Burger JWA.